• S&P 500: 1,340.01
  • Change: -0.88%
$3.02 -0.20 (-6.19%)
2/10/2012 10:19 AM

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Current Price $3.02 Mkt Cap $148.20M
Open $3.20 P/E Ratio 0.00
Prev. Close $3.22 Div. (Yield) N/A (N/A)
Daily Range $3.00 - $3.22 Volume 458,264
52-Wk Range $1.18 - $4.08 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think THLD will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

51 Outperform
15 Underperform
 

All-Star Players

13 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top THLD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

portefeuille (99.82)
Submitted December 16, 2011

There are currently 4500 THLD shares in my "fund" with break-even of around 0.04 USD. http://caps.fool.com/Blogs/fund-trades/678775.

1 Comment | Reply | Report this Post

zzlangerhans (99.32)
Submitted January 26, 2011

Threshold has been gleefully destroying shareholder value for as long as I've been following biotech. The tried and true formula: Initiate trial. Dilute. Trial fails. Dilute. Reverse split. Initiate trial. Rinse, lather, repeat. Four years ago… More

1 Comment | Reply | Report this Post
THLD VS S&P 500 (SPY)

Fools bullish on THLD are also bullish on:

Fools bearish on THLD are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about THLD.

Recs

0
Member Avatar CrowdKnowsBest (< 20) Submitted: 2/6/2012 8:19:13 PM : Outperform Start Price: $3.24 THLD Score: -6.73

Getting in late, hope the stock continues its momentum. February and March are supposed to be big for biotech with FDA announcements.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar STAINEDGLASSER (76.38) Submitted: 2/6/2012 1:26:49 PM : Outperform Start Price: $3.63 THLD Score: -16.60

They have numerous cancer drugs in the works that appear to be doing well in clinical trials. They recently inked a deal with Merck in Germany to commercialize one of their drugs, which is also an indication that they are doing well.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar hiddenflem (81.04) Submitted: 2/3/2012 2:01:56 PM : Outperform Start Price: $2.20 THLD Score: +37.22

Factor in the money they got from Merck today along with the presumption that the first milestone will be met (otherwise why would Merck be partnering with them) and this looks cheap. very cheap.

Report this Post 3 Comments | Reply | Permalink
View All 12 Pitches »

Leaderboard

Find the members with the highest scoring picks in THLD.

Score Leader

jack0071

jack0071 (91.27) Score: +158.83

The Score Leader is the player with the highest score across all their picks in THLD.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
jack0071 90.53 12/30/2011 Outperform 3Y $1.21 +149.43% +6.42% +143.01 0 Comment
portefeuille 99.82 12/13/2011 Outperform 3W $1.35 +123.75% +7.48% +116.27 2 Comments
DrLeopold2010 < 20 8/22/2011 Outperform 5Y $1.37 +120.48% +16.45% +104.04 0 Comment
topsecret10 22.96 4/1/2011 Outperform 5Y $1.60 +88.79% +0.31% +88.47 1 Comment
carsondyle 74.56 8/4/2011 Outperform 5Y $1.57 +92.39% +7.79% +84.61 0 Comment
cfpmba92 < 20 3/30/2011 Outperform 5Y $1.66 +81.95% +1.15% +80.81 0 Comment
jah609 62.11 6/6/2011 Outperform 5Y $1.65 +83.08% +3.71% +79.37 0 Comment
PharmaD 62.20 10/27/2011 Outperform 1Y $1.67 +80.87% +5.08% +75.80 0 Comment
SorrySam 73.63 3/21/2011 Outperform 5Y $1.69 +78.73% +3.68% +75.05 1 Comment
tempttempt 71.93 3/17/2011 Outperform 5Y $1.75 +72.61% +4.77% +67.83 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for THLD.

Featured Broker Partners